Univariate survival analysis showed that breast cancer patients with negative nuclear staining of the WRAP53 protein had a statistically significantly increased mortality compared to patients with positive nuclear staining (HR = 1.95, 95%CI = 1.09–3.51, p = 0.025; Fig 2A, S5 Table). Here, WRAP53 is linked to breast carcinoma.